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ABSTRAK 
Tarigan S, Sumarningsih, Ignjatovic J. 2015. Reliabilitas tes DIVA berbasis M2e jauh lebih tinggi dibandingkan dengan tes 
DIVA berbasis HA2 atau protein NS1. JITV 20(2): 126-133. DOI: http://dx.doi.org/10.14334/jitv.v20i2.1167 
Salah satu kelemahan utama vaksinasi pada avian influenza adalah bahwa vaksinasi tersebut tidak dapat memberikan 
perlindungan terhadap infeksi. Bila peternakan yang menerapkan vaksinasi terpapar virus dalam jumlah besar, infeksi subklinis 
dapat menyebar dalam peternakan tersebut dalam waktu yang lama tanpa diketahui. Kondisi tersebut hanya dapat dimonitor 
dengan alat tes DIVA (differentiation of infected from vaccinated animals), alat uji konvensional tidak dapat digunakan. Tes 
DIVA berdasarkan antibodi yang terbentuk akibat stimulasi virus bereplikasi merupakan tes DIVA yang paling sesuai. Untuk 
influenza H5N1 antibodi yang dimaksud antara lain antibodi terhadap M2e, protein NS1 dan peptida HA2 (HA_488-516). 
Tujuan penelitian ini adalah membandingkan level antibodi terhadap peptida M2e, NS1 dan HA2 pada ayam normal, vaksinasi 
dan infeksi (1, 2-3, ≥4 minggu pasca infeksi). Level antibodi diukur dengan ELISA menggunakan sintetik peptida sebagai 
antigen koting. Peptida yang digunakan antara lain: 4 buah peptida NS1 yang didasarkan pada berbagai lokasi pada protein NS1, 
peptida M2e dan HA2. Semua peptida dibiotinilasi pada ujung N nya. Koting peptida  pada microtitre plate dilakukan secara 
langsung atau melalui jembatan streptavidin. Penelitian ini menunjukkan bahwa vaksinasi tidak merangsang pembentukan 
antibodi terhadap semua peptida. Ayam yang terinfeksi membentuk antibodi dengan level yang tinggi terhadap peptida M2e, 
tetapi sangat rendah terhadap peptida NS1 dan HA2. Antibodi terhadap peptida NS1 dan HA2 hanya dapat dideteksi dengan 
ELISA streptavidin-peptida. ELISA berbasis NS1 atau HA2 tidak dapat diandalkan sebagai tes DIVA untuk penyakit AI H5N1 
pada ayam. 
Kata Kunci: M2e, Protein NS1, Peptida HA2, Tes DIVA, H5N1 
ABSTRACT 
Tarigan S, Sumarningsih, Ignjatovic J. 2015. The reliability of DIVA test based on M2e peptide exceed those based on HA2 or 
NS1 peptides. JITV 20(2): 126-133. DOI: http://dx.doi.org/10.14334/jitv.v20i2.1167 
One of the most important disadvantage of vaccination against avian influenza is that it cannot protect vaccinated birds 
against infection. When vaccinated poultry are heavily exposed to the virus, prolonged, unrecognised, subclinical infection may 
persist on the farm. The condition can only be serologically monitored by a DIVA (differentiation of infected from vaccinated 
animals) test, whereas conventional diagnostic tests cannot be used. The DIVA tests based on an antibody response following 
virus replication is the most appropriate approach. For H5N1 influenza such antibodies includes those to the M2e and NS1 
proteins and an epitope on the HA2 subunit (HA_488-516). The purpose of this study was to compare the magnitude of the 
antibody  response in chickens vaccinated and infected with an H5N1 virus strain. For that purpose, sera collected from naïve, 
vaccinated and infected  birds, at 1, 2-3, ≥4 weeks post challenge were used. Antibodies were measured by ELISA using 
biotinylated synthetic peptides as coating antigens. The peptides used include four NS1 peptides corresponding to different 
regions of the NS1 protein and HA_488-516and M2e peptides. Peptides were coated onto microtitre plates either directly or via 
a streptavidin bridge. The results showed that vaccination did not cause antibody conversion to any of the peptides, where as 
challenged birds developed a high antibody response to M2e but, low response to the NS1 and HA2 peptides. Antibodies to the 
later peptides were detected only by the streptavidin-peptide ELISA. The ELISA based on NS1 or HA_488-516 peptides, 
therefore, are not reliable for use as DIVA test in H5N1 avian influenza virus infection. 
Key Words: M2e, NS1 Protein, HA2 Peptide, DIVA Test, H5N1 
INTRODUCTION 
One of the most important draw backs of avian 
influenza vaccination in poultry is the difficulty in 
disease surveillance. Vaccination provides protection 
against clinical disease and reduces the amount of virus 
shed by the infected birds, but it cannot provide 
complete protection against virus infection (Savill et al. 
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2006). When a vaccinated flock is exposed to HPAI 
virus challenge, it may result in subclinical infection 
that continues to circulate in the flock unrecognized by 
the farmers. This situation is compounded by the fact 
that a practical diagnostic tool is not available that can 
be used to detect the presence of subclinical infection. 
The common serological test such as HI test, ELISA or 
Agar gel precipitation test could not be used, as they are 
unable to differentiate between antibodies in birds due 
to infection and those due to vaccination. Virus 
isolation, PCR or rapid antigen detection test are either 
too expensive or insensitive. 
Serological test that can identify infected among 
vaccinated birds are termed DIVA (Differentiation of 
Infected from Vaccinated Animals) test. Different 
DIVA strategies for avian influenza have been reviewed 
previously (Suarez 2005; Tarigan 2015). DIVA strategy 
based on heterologous-neuraminidase was successfully 
applied in Italy (Capua et al. 2003; Capua et al. 2004). 
The prerequisite was that the vaccine used had to be 
generated from virus subtypes with neuraminidase 
heterologous to that of circulating virus, preventing the 
application of this strategy in other countries, including 
Indonesia. In addition, the indirect iFAT (fluorescent 
antibody test) used to identify infected birds in this 
strategy is also not practical. 
Unlike DIVA test based on heterologous-
neuraminidase, DIVA test based on the external domain 
of M2 protein (M2e) is independent from the vaccine 
subtype since antibodies to M2e develop only in 
infected animals but not in vaccinated with killed AIV 
vaccines. ELISA based on either synthetic M2e peptide 
or bacterial expressed M2e protein has been used to 
measure the M2e antibody response (Lambrecht et al. 
2007; Kim et al. 2010; Hemmatzadeh et al. 2013; 
Hadifar et al. 2014; Tarigan et al. 2015). The M2e-
ELISA was reported to have high specificity but rather 
low sensitivity. The low sensitivity is attributed to the 
fact that M2e antibody can be detected in birds not 
sooner than 7 days of infection, and also some birds fail 
to seroconvert to M2e. Additional DIVA test capable of 
detecting infection in those M2e-negative, but infected 
birds, would be advantageous in order to increase the 
sensitivity of DIVA testing. The purpose of this study 
was to investigate the possibility of an ELISA test 
based on the influenza virus nonstructural-1 (NS1) 
protein and also on the recently identified epitope in the 
HA2 domain of haemagglutinin H5 (HA_488-516) as 
possible supplements to the M2e DIVA test (Khurana et 
al. 2011). This possibility was investigated by 
comparing the magnitude of the antibodies to those 
proteins or peptides in naïve, vaccinated and infected 
chickens. 
The NS1 protein is the only true non-structural 
protein in Influenza viruses and interest in developing 
DIVA tests based on this protein have been considered. 
However, the accuracy of test based on this protein as 
DIVA test is still contradictory between different 
studies. Some studies found that the NS1 based tests are 
sensitive and specific as DIVA test (Birch-Machin et al. 
1997; Golchinfar et al. 2014; Ozaki et al. 2001; 
Takeyama et al. 2011), while others have found the 
reverse (Avellaneda et al. 2010). In this study, the 
accuracy of NS1-based ELISA as DIVA test was 
evaluated thoroughly by analyzing different fragments 
of the protein and different condition of ELISA. In 
addition, antibody to an epitope in the HA2 domain of 
haemagglutinin H5 (HA_488-516) suggested as being a 
reliable marker for H5N1 infection in human, has yet to 
confirmed in poultry (Khurana et al. 2011). 
MATERIALS AND METHODS 
Peptide 
Four NS1 peptides, one HA peptide, and M2e 
peptide were synthesized by VCPBIO Inc. China. 
Following are the location and amino acid sequences of 
the peptides NS1_34-49 (Biotin-DRLRRDQKSLR 
GRGNT), NS1_23-42 (Biotin-ADQELGDAPFL 
DRLRRDQKS), NS1_87-98 (Biotin-TDMTLEEM 
SRDW), NS1_221-233 (Biotin-QKRKMARTIESEV), 
HA_488-516 (Biotin-DYPQYSEEARLKREEISG 
VKLESIGIYQI), M2e (Biotin-MSLLTEVETPTR 
NEWECRCSDSSD). All peptides, which were 
biotinylated at the N-terminal, had at least 90% purity. 
Serum 
Sera used in this study were collected from chicken 
experimentally infected with H5N1 influenza virus 
(A/Chicken/WestJava/Sbg-29/2007). The challenge 
experiment had been described in our previous study 
(Tarigan et al. 2015). Briefly, 200 layer chicken were 
divided into 4 groups (A, B, D and C). Groups A, B, 
and D were vaccinated with a commercial-killed-H5N1 
vaccine 3, 2 and 1 times, respectively. Group C birds 
were not vaccinated and served as a control. Two weeks 
after the last vaccination, randomly selected birds from 
each groups including the control were challenged with 
an isolate of H5N1 virus. For the current experiment, 18 
sera from each group of pre-vaccination, post 
vaccination, 1, 2-3, and ≥4 weeks post challenge were 
selected. 
Direct-peptided- and streptavidin-peptided-coated 
ELISA 
Two types of ELISA were used based on the 
method used for coating the peptides on the 96-well 
microtitre plate. In the first ELISA, each biotinylated 
peptide was disolved in carbonate buffer (pH 9.6) at 5 
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µg/ml then added to the plates at 100µl/well). After 
leaving at 4°C overnight, the plate was blocked with 5 
mg/ml of non-fat-skim milk in PBS (pH 7.2), 150 
µl/well for 2 hours. Serum diluted at 1:100 in 
PBST(PBS, 0.5% Tween 20) supplemented with 5% 
normal rabbit serum was added at 100 µl/well, then 
incubated at 37°C for 2 hours. In each plate, negative 
control SPF chicken serum was added. After washing 
four times with PBST, HRP-rabbit-anti-chicken IgG 
conjugate (Sigma Co.) diluted 1:5000 in PBST 
supplemented with 5% normal rabbit serum was added, 
then incubated at 37°C for 2 hours. After washing four 
times with PBST, solution of substrate and 
chromogenic ABTS was added and the absorbance 
(A420) measured with a spectrophotometer microtitre 
plate reader. 
In the second type of ELISA, streptavidin disolved 
in carbonate buffer at 4 µg/ml, was added 100 µl/well, 
and left overnght at 4°C. Streptavidin used in this study 
was produced in the previous study (Tarigan & 
Sumarningsih 2014). After washing four times with 
PBST, biotinylated peptide diluted in PBS at 5 µg/ml 
was added at 100 µl/well. The plate was blocked with 
skim milk and the remining procedures were the same 
as in the first type of ELISA.  
A preliminary assay was carried out to prove that 
streptavidin coated to the plates did specifically bind to 
the biotin, and to determine the optimum concentration 
of streptavidin for the assay. Streptavidin was diluted to 
4, 2, 1, 0.5, 0µg/ml in carbonate buffer and added to 
mocrotitre plate at 100 µl/well. After leaving at 4°C 
overnight, the plate was blocked with skim milk for 2 
hours. Biotynilated chicken IgY, produced in the 
previus study (Tarigan et al. 2015), was added at 1:1600 
and 1:3200  dilution in PBS and incubated at 37°C for 2 
hours. After washing four times with PBST, HRP-anti 
chicken IgG (Sigma Co.) at 1: 5000 dilution was added 
and incubated at 37°C for 2 hours. After washing four 
times with PBST, solution of substrate and 
chromogenic ABTS was added and the absorbance 
(A420) measured with a spectrophotometer microtitre 
plate reader. 
Statistical analysis 
The level of antibody, indicated by ELISA’s OD, to 
each peptide in each group of bird (pre-vaccination, 
post-vaccination, 1-week-post challenge, 2-3-week-post 
challenge, and ≥4-week-post challenge) was presented 
as the mean and 95% confidence interval of the mean of 
the ELISA’s OD. Differences between groups were 
analised by one-way ANOVA (analysis of variance). 
All statistical analyses were carried out using a 
commercial statistical package (IBM® SPSS® 
Statistics). 
RESULTS AND DISCUSSION 
Results 
Antibodies to NS1, HA_488-516 and M2e, 
measured by direct peptide ELISA in chickens of 
various immune or infection status, are presented in 
Figure 1. No antibody to any of the four NS1 peptides, 
the HA_488-516 peptide or M2e peptide was detected 
in chickens before and after vaccination. Antibody to 
M2e rose markedly after 1 week and remained high for 
several weeks after challenge. Unlike antibody to M2e, 
no antibody conversion was observed to any of the NS1 
or HA_488-516 peptides. 
There are two possibilities regarding the lack of 
measurable antibody conversion to the NS1 and HA2 
peptides. The first possibility was that antibodies did 
not develop in those infected birds. This possibility 
seemed unlikely because antibody to NS1 should be 
detected whenever replication of influenza virus take 
place in immuno-competent animals. The strong 
antibody response to M2e indicated that a substantial 
replication of H5N1 virus must have had taken place in 
those infected birds. The second possibility was that the 
direct peptide ELISA used in this study was not 
sensitive enough to detect the presence of NS1 or 
HA_488-516 antibodies. Onepossible cause of this 
insensitivity was that the NS1 and HA2 peptides did not 
bind to the plates, or were unable to bind the antibodies 
once the peptides were immobilised on the plates. This 
problem was aliviated by the use of  the streptavidin-
peptide ELISA.  
When added to the streptavidin-coated, protein-
blocked plates, biotinyl-IgY was bound to the plate 
efficiently. In contrast, no biotinyl-IgY was retained 
when added to a non-streptavidin-coated, protein-
blocked plates (Figure 2). This results indicated that the 
binding activity of streptavidin coating was specific and 
efficient. The concentration of streptavidin on coated 
plates that maximally bound the biotinyl IgY was 
around 4 µg/ml, and this concentration was used in all 
assays in this study. When the streptavidin-peptide 
ELISA was used to assay the chicken sera, the results, 
regarding antibody to M2e, were comparable to the 
direct peptide ELISA described above.  
This streptavidin-peptide ELISA, however, was able 
to show that the level of antibody to all peptides in the 
sera  of infected birds were higher than those in the 
non-infected birds (Figure 3). Although the increase of 
antibodies were only slight, they were statistically 
significant (P>0.05). The  statistically significant 
increases or differences were between pre-vaccinated 
and challenged (≥4 wpi), and post-vaccinated and 
challenged (≥4 wpi) sera, to all peptides (Table 1).  
Tarigan et al. The reliability of DIVA test based on M2e peptide exceed those based on HA2 or NS1 peptides 
129 
 
 
Pre Vac   = Pre vaccination;  
Post Vac   = 2 week post vaccination (1, 2 and 3 times vaccination);  
Chl 1 wpi  = 1 week post challenge;  
Chl 2-3 wpi  = 2 and 3 weeks post challenge;  
Chl ≥ 4wpi   = 4 week or longer after infection or challenge 
Figure 1. Antibody conversions to four NS1, HA_488-516 and M2e peptides in chickens after vaccination and challenge with H5N1 
virus  
 
Figure 2. Binding of biotinylated IgY to streptavidin coated onto wells of microtitre plate. Biotinylated IgY was added to streptavidin-
coated, protein-blocked microtitreplate. The biotinylated IgY bound to streptavidin was detected by HRP-anti-chicken IgG 
and the quantity of biotinylated IgY bound to the strepatvidin was correlated with the ELISA’s OD 
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Pre Vac  = Pre vaccination;  
Post Vac  = 2 week post vaccination (1, 2 and 3 times vaccination);  
Chl 1 wpc  = 1 week post challenge;  
Chl 2-3 wpc = 2 and 3 weeks post challenge; 
Chl ≥4 wpc  = Post challenge 4 week or longer 
Figure 3. Antibody conversions to NS1, HA2 and M2e peptides in chicken after vaccination and challenge with H5N1 virus 
Table 1. Antibody to NS1 (NS1_23-42, NS1_34-49, NS1_87-98, NS1_221-233), HA2 and M2e peptides in chickens that 
increased significantly (P<0.05) after challenge with H5N1 ELISA streptavidin 
  
1 week post 
challenge 
2 and 3 weeks 
post challenge 
Post 
challenge 
4 week or 
longer 
 
NS1_23-42 
Pre vaccination    
2 week post vaccination (1, 2 and 3 times vaccination)    
1 week post challenge    
2 and 3 weeks post challenge    
NS1_34-49 
Pre vaccination    
2 week post vaccination (1, 2 and 3 times vaccination)    
1 week post challenge    
2 and 3 weeks post challenge    
NS1_87-98 
Pre vaccination    
2 week post vaccination (1, 2 and 3 times vaccination)    
1 week post challenge    
2 and 3 weeks post challenge    
NS1_221-233 
Pre vaccination    
2 week post vaccination (1, 2 and 3 times vaccination)    
1 week post challenge    
2 and 3 weeks post challenge    
HA_488-516 
Pre vaccination    
2 week post vaccination (1, 2 and 3 times vaccination)    
1 week post challenge    
2 and 3 weeks post challenge    
M2e 
Pre vaccination    
2 week post vaccination (1, 2 and 3 times vaccination)    
1 week post challenge    
2 and 3 weeks post challenge    
 = Antibody (ELISA OD) was significantly increased (P<0.05) 
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No differences in all antibodies between pre and 
post-vaccinated sera. The level of antibody to NS1_87-
98 peptide was significantly higher in the 1-week-post-
challenge sera than in pre- and post-vaccinated sera. 
The higher level at the 1-week-post-challenge sera was 
not observed in antibody to other peptides, even that to 
M2e. 
Discussions 
This study shows that M2e-based ELISA is superior 
to NS1- or HA2-based ELISA as DIVA test. As far as 
we are aware, no study has been carried out previously 
comparing M2e ELISA and NS1-peptide-based ELISA 
as DIVA test. 
Influenza-NS1 protein consists of 230 amino acids 
and two functional domains: the RNA-binding (aa 
residues 1-73) and the effector domain (aa residues 74-
230). The RNA binding domain funtions to inhibit 
action of interferon (Donelan et al. 2003; Min & Krug 
2006). The effector domain functions to enhance viral 
mRNA translation, deregulate cellular mRNA 
processing, inhibit dsRNA-activated protein kinase and 
activate phosphoinositide 3-kinase (PI3K) signaling 
(Hale et al. 2008). 
The NS1 protein is the only true non-structural 
protein in influenza viruses (Donelan et al. 2003). Being 
the non-structural protein, it is expressed only during 
viral replication inside the host cells but the protein is 
not packed into the virion. Driven by the assumption 
that animals vaccinated with killed AIV vaccines do not 
develop specific antibodies to the NS1 protein, as do 
animals infected by life virus, interest in developing a 
DIVA test based on the NS1 protein has been long 
present. However, there is still disagreement between 
different studies on the accuracy of NS1-based ELISA 
used as DIVA test. Most studies showed that NS1-
based tests had low accuracy as a DIVA test, as was 
found in this present studies (Tumpey et al. 2005; 
Dundon & Capua 2009; Avellaneda et al. 2010). Other 
studies, however, indicated that NS1-based ELISA 
ispotentially useful as DIVA test (Birch-Machin et al. 
1997; Ozaki et al. 2001; Tumpey et al. 2005; Takeyama 
et al. 2011; Wang et al. 2011; Golchinfar et al. 2014). In 
spite of that potential of NS1-based ELISA as DIVA 
test, the test had rather low specificity because some 
vaccinated animals were also seropositive although with 
low antibody titres. The NS1 antibodies are presumed 
to be induced by the NS1 protein derived from cellular 
debris of chicken embryo contaminating the vaccines 
(Tumpey et al. 2005). The NS1 ELISA has not only low 
specificity but also low sensitivity. The low sensitivity 
is associated with the nature of the protein that is poorly 
immunogenic. The NS1 antibody is usually in low titre 
and rapidly disappears (Tumpey et al. 2005; Avellaneda 
et al. 2010). Immune response to NS1 may also be 
species-dependent. An experimental study reported that 
infection of chicken with a LPAI isolate caused 
antibody conversion to NS1 protein only in 3 of 14 
birds, and the antibody was detected only at day-3 post 
infection. Infection of turkey with the same isolate 
produced higher proportion of seroconversion and the 
antibody was detected at day-5 to day-10 post infection 
(Dundon & Capua 2009). 
There are several possible causes of the NS1-
antibody undetectable in infected chicken. The first 
possible cause is that the assay used is not sensitive 
enough to detect the presence of the antibodies. In this 
present study, four synthetic peptides with amino acid 
sequence based on the regions of the protein considered 
to be immunogenic based on hydrophobic analysis. A 
peptide comparable to that NS1_34-49 in this study has 
previously been demonstrated to be sensitive when used 
as coating in ELISA in detecting NS1 antibody 
(Tumpey et al. 2005). Test based on peptide NS1_23-42 
that proceeds at the N-terminal, and overlaps 9 amino 
acids with NS1_34-49 also failed to detect the presence 
of NS1 antibody. As a matter of fact, Tumpey et al. 
2005 shows that the peptide is more specific, although 
less sensitive, than the recombinant–whole-NS1 
protein. This finding lend support to the opinion that 
ELISA based on the whole-NS1 protein is not necessary 
more accurate than that bases on NS1-synthetic peptide 
in detecting the antibody to the NS1 protein.  
The C terminal end of NS1 protein that contain the 
PDZ-ligand binding motif (PBM), ESEV, has been 
proven to be immunogenic, and animals infected by 
influenza viruses become seroconverted to synthetic 
peptides which sequence is based on the C terminal part 
of the NS1 protein (Birch-Machin et al. 1997; Dundon 
et al. 2006). In this present study, however, the sera 
from infected birds did not contain antibody to a 
comparable peptide, NS1_221-233, assayed with the 
direct-peptide coating ELISA. 
Sera from human survived from H5N1-virus 
infection have been shown to contain antibody to a 
HA2 peptide, HA_488-516 (Khurana et al. 2011). The 
antibody reported to be specific for H5N1-virus 
infection as it was not detected in sera from human 
vaccinated or infected with seasonal influenza virus, or 
vaccinated with subunit H5N1 vaccine (Khurana et al. 
2011). These results suggest that the peptide deem a 
good candidate for DIVA test in poultry. However, our 
study showed that the infected birds failed to be 
positively converted to the same HA_488-516 peptide. 
It is not only the peptides themselves, the ELISA 
format, the direct coatingof peptides onto the wells of 
ELISA plates, used in this study was also similar to the 
previous studies (Tumpey et al. 2005; Dundon et al. 
2006). Therefore, the probability that the peptides were 
notimmobilised on the microtitre plate as the cause of 
the failure to detect the NS1 antibody in sera of 
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challenged birds in our study seems unlikely. This 
possibility was partially ruled out by the streptavidin-
peptide ELISA. The streptavidin coated onto the plates 
has been shown to specifically bind to biotinyl 
substances. Since the peptides used were all 
biotinylated at the N terminal, the peptide were 
expected tobind to the plate only through its N-terminal 
‘tip’; consequently, if asample serum contains NS1 
antibody, it should react with the immobilised peptide 
efficiently. The fact that the ELISA’s ODs of 
challenged sera increased significantly as compared to 
those before challenge indicated that the streptavidin-
peptide coated ELISA is more sensitive than the direct-
peptide coated ELISA. Since the increased were only 
slight even in the improved assay, it indicates that the 
conversion of antibody to NS1 protein in the infected 
birds is only mild and only detected by a very sensitive 
assay. 
In summary, this study shows that antibody to either 
M2e, HA_488-516, NS1 peptides, are absent in bird 
naïve or vaccinated with killed H5N1 vaccines. 
Antibody conversion to M2e is more consistent and its 
magnitude is much higher than that to HA_488-516 and 
peptide NS1 peptides. Consequently, M2e-based is 
much more reliable than NS1- or HA2-based ELISA as 
DIVA test. Antibody conversion to HA_488-516 and 
peptide NS1 in infected chickens is extremely mild and 
therefore difficult to detect.  
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